Effects of novel quinoid thiosulfonate derivative on ADP-induced platelet aggregation
Author(s) -
Tetiana Halenova,
I. Nikolaieva,
О. Savchuk,
Khrystyna Bolibrukh,
Svyatoslav Polovkovych,
Volodymyr Novikov
Publication year - 2014
Publication title -
bulletin of taras shevchenko national university of kyiv series biology
Language(s) - English
Resource type - Journals
ISSN - 1728-2748
DOI - 10.17721/1728_2748.2014.68.36-40
Subject(s) - chemistry , derivative (finance) , platelet , platelet aggregation , platelet aggregation inhibitor , stereochemistry , inhibitory postsynaptic potential , adenosine diphosphate , pharmacology , biophysics , biochemistry , medicine , biology , aspirin , financial economics , economics
Recently, in a large scale screening test, we have found that S-((1,4-dimethoxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl)4-aminobenzenesulfonothioate, a chemically synthesized thiosulfonate derivative of quinone, possessed an antiplatelet activity. To elucidate the mechanism of its antiplatelet action, a series of experiments were performed. The compound was found to inhibit the ADP-induced platelet aggregation. The inhibitory effect was dose-dependent on concentration and preincubation time. The derivative also disaggregated the preformed platelet aggregates induced by ADP.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom